Antiviral therapies for respiratory viral infections in lung transplant patients

Michael G. Ison*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Because the lung is in constant contact with the environment, infections with respiratory viruses are a common and potentially serious complication of lung transplantation. Infection can cause direct effects, typically manifested as respiratory symptoms and changes in pulmonary function, and indirect effects, such as an enhanced risk of developing chronic allograft rejection. Infections with all of the identified respiratory viruses have been associated with infection in lung transplant recipients. Specific antiviral options have been studied for influenza and respiratory syncytial virus, and investigational agents are in development for other respiratory viruses. This paper will review the epidemiology and management strategies of respiratory viral infections in lung transplant recipients.

Original languageEnglish (US)
Pages (from-to)193-200
Number of pages8
JournalAntiviral Therapy
Volume17
Issue number1 PART B
DOIs
StatePublished - May 3 2012

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Antiviral therapies for respiratory viral infections in lung transplant patients'. Together they form a unique fingerprint.

Cite this